Stay updated on Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-11T16:58:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a Revision: v3.4.2 to the history; removed the prior funding-status notices about lapses and operating updates.
    Difference
    0.3%
    Check dated 2026-02-11T02:39:49.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding/operational status notice and updated the page revision to v3.4.1 (replacing v3.4.0). These changes do not alter the trial record content.
    Difference
    0.3%
    Check dated 2026-02-04T01:50:32.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The BI 754091 platform trial description was deleted and replaced with an Ezabenlimab-based platform trial description, and a new 'Results Posted' entry was added, with color-coded changes for Adverse Events, Outcome Measures, IPDSharing, and Study Status. The update also enables 'Show glossary' and documents the 3.4.0 revision with UI cues about how additions and deletions are presented.
    Difference
    0.8%
    Check dated 2026-01-28T00:27:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page, representing a minor site update with no impact on study records or history content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:42:33.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Latest revision v3.3.3 (2025-12-03) adds several record sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, IPDSharing, Contacts/Locations, Eligibility, Study Description, Study Status) and shows Returned: 2025-12-18, while removing the HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-12-23T10:09:56.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Anti-PD-1 Combination Therapies Clinical Trial page.